Related Experiment Video

Updated: Mar 25, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

13.8K

CAMK4 gene variation is associated with hypertension in a Uygur population

S Z Chen1,2, Z Wang1,2, L N Zhang1

  • 1Department of Internal Medicine and Genetic Diagnosis Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Genetics and Molecular Research : GMR
|February 25, 2016
PubMed

Insights

The calcium/calmodulin-dependent kinase 4 (CAMK4) rs10491334 polymorphism is linked to hypertension risk in the Uygur ethnic group. This genetic variation was not significantly associated with hypertension in Han and Kazak populations.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Pharmacogenomics

Background:

  • Calcium/calmodulin-dependent kinase 4 (CAMK4) is crucial for regulating blood pressure.
  • Genetic variations in CAMK4 may influence hypertension susceptibility.
  • Ethnic differences in genetic associations are common in complex diseases.

Purpose of the Study:

  • To investigate the association between the CAMK4 rs10491334 polymorphism and hypertension.
  • To examine potential ethnic disparities in this association among Han, Kazak, and Uygur populations.

Main Methods:

  • A case-control study involving 1224 hypertensive patients and 967 normotensive controls.
  • Genotyping of the rs10491334 polymorphism using a TaqMan® 5'-nuclease assay.
  • Statistical analysis to compare allele frequencies and assess hypertension risk across ethnic groups.

Main Results:

  • The T-allele frequency of rs10491334 was significantly higher in hypertensive Uygurs compared to controls (12.5% vs. 6.38%).
  • Carriers of the T-allele in the Uygur group exhibited a 2.2-fold increased risk of hypertension (OR = 2.200, P < 0.001).
  • No significant association between the rs10491334 polymorphism and hypertension was observed in the Han and Kazak groups.

Conclusions:

  • The T-allele of the CAMK4 rs10491334 polymorphism is associated with an increased risk of hypertension specifically in the Uygur ethnic group.
  • This finding highlights potential ethnic-specific genetic factors contributing to hypertension.
  • Further research is warranted to elucidate the mechanisms underlying this ethnic-specific association.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.9K

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
108
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
710
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.7K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K